alanine has been researched along with niacinamide in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (22.58) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 15 (48.39) | 24.3611 |
| 2020's | 4 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Tritz, GJ; Williams, MV | 1 |
| Miller, SM; Moore, MJ; Walsh, CT | 1 |
| Rodwell, AW | 1 |
| Asatoor, AM; Navab, F | 1 |
| Curzon, G; Green, AR | 1 |
| Bruice, TC; Shinkai, S | 1 |
| Fuji, M; Fukumoto, Y; Nagamatsu, A; Shimeno, H | 1 |
| Bahnson, BJ; Chin, JK; Colby, TD; Goldstein, BM; Klinman, JP | 1 |
| CONTRERAS, E; CROXATTO, R; HUIDOBRO, F | 1 |
| Lamers, RJ; Schaafsma, G; van de Sandt, JJ; van der Greef, J; van Nesselrooij, JH; Venema, K; Wessels, EC | 1 |
| van der Donk, WA; Woodyer, R; Zhao, H | 1 |
| Kapoor, M; Mukhi, PL; Suguna, K; Surolia, A; Surolia, N | 1 |
| Allen, E; Hanahan, D; Walters, IB | 1 |
| Bondinell, W; Carpenter, DC; Dong, X; Jin, Q; Keller, PM; Kerns, JK; Mitchell, L; Nevins, N; Nie, H; Podolin, PL; Rahman, A; Riflade, B; Tomaszek, T; Widdowson, KL; Yamashita, DS | 1 |
| Chen, L; Lei, Y; Melgiri, ND; Meng, H; Wang, Y; Xie, P; Yang, D; Zheng, P; Zhong, J; Zhou, D | 1 |
| Chang, AY; Wang, M | 1 |
| Agris, PF; Fanning, KD; Francis, SP; Harris, KA; Katz, J; Lacy, M; Nicholas, BD; Pagana, J; Shin, JB | 1 |
| Boucher, E; Chao, Y; Cheng, AL; Decaens, T; Ezzeddine, R; Han, KH; Heo, J; Hsu, CH; Hu, TH; Jeng, LB; Johnson, PJ; Komov, D; Kudo, M; Liu, D; Lu, L; Paik, SW; Park, JW; Philip, PA; Poon, RT; Qin, S; Raoul, JL; Robles-Aviña, J; Sobhonslidsuk, A; Tak, WY; Walters, I; Xu, J; Yan, L | 1 |
| Kelley, RK | 1 |
| Assenat, E; Blanc, JF; Boige, V; Boucher, E; Bruix, J; Chang, C; Chao, Y; Decaens, T; Ezzeddine, R; Fartoux, L; Finn, RS; Kang, YK; Kudo, M; Lim, HY; Lin, DY; Liu, D; Llovet, JM; Mathurin, P; Park, JW; Poon, RT; Raoul, JL; Sherman, M; Tak, WY; Walters, I | 1 |
| Hsieh, YC; Huang, YT; Lee, FY; Lee, KC; Lee, PC; Lee, WP; Lin, HC; Liu, RS; Tan, TW; Yang, YY; Yeh, YC | 1 |
| Fan, D; Han, G; Jia, J; Qi, X | 1 |
| Johnson, PJ; Llovet, JM | 1 |
| Nogowski, L; Szkudelska, K; Szkudelski, T | 1 |
| Bolos, D; Finn, RS | 1 |
| Kalyan, A; Kulik, L; Nimeiri, H | 1 |
| Costentin, C; Decaens, T; Diao, G; Duvoux, C; Katsahian, S; Laurent, A; Luciani, A; Mallat, A; Nault, JC; Nelson, AC; Pigneur, F; Tselikas, L | 1 |
| Akihiro, T; Kawai, K; Makino, Y; Nishizaka, A; Sotome, I; Yoshimura, M | 1 |
| Chen, K; Dai, Y; Guo, J; Jiang, H; Jiang, N; Wang, L | 1 |
| Aho, VTE; Aurich, D; Bolton, EE; Cheng, T; Mollenhauer, B; Schymanski, EL; Singh, RR; Talavera Andújar, B; Wilmes, P; Zaslavsky, L | 1 |
| Chen, L; Gu, J; Huang, C; Kong, Q; Lin, D; Lu, R; Wu, W | 1 |
1 review(s) available for alanine and niacinamide
| Article | Year |
|---|---|
Systemic therapy of hepatocellular carcinoma: current and promising.
Topics: Alanine; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Hepatectomy; Humans; Indoles; Liver Neoplasms; Liver Transplantation; Niacinamide; Phenylurea Compounds; Preoperative Care; Proto-Oncogene Proteins c-met; Pyrroles; Signal Transduction; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases; Triazines | 2015 |
2 trial(s) available for alanine and niacinamide
| Article | Year |
|---|---|
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Carcinoma, Hepatocellular; Double-Blind Method; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Sorafenib; Survival Rate; Triazines; Young Adult | 2013 |
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Carcinoma, Hepatocellular; Double-Blind Method; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Salvage Therapy; Sorafenib; Survival Rate; Triazines; Young Adult | 2013 |
28 other study(ies) available for alanine and niacinamide
| Article | Year |
|---|---|
Studies on the modes of action of azaserine inhibition of Escherichia coli. Potentiation of phenylalanine reversal.
Topics: Alanine; Asparagine; Azaserine; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Glutamine; Methionine; Mutation; Niacinamide; p-Fluorophenylalanine; Phenylalanine; Stereoisomerism | 1977 |
C-terminal cysteines of Tn501 mercuric ion reductase.
Topics: Alanine; Base Sequence; Binding Sites; Catalysis; Cysteine; Escherichia coli; Kinetics; Mercuric Chloride; Mercury; Molecular Sequence Data; Mutagenesis, Site-Directed; Niacinamide; Oxidation-Reduction; Oxidoreductases; Phenotype; Spectrophotometry; Structure-Activity Relationship; Sulfhydryl Compounds; Transformation, Bacterial | 1992 |
A defined medium for Mycoplasma strain Y.
Topics: Alanine; Amino Acids; Culture Media; Esters; Glycerides; Glycerol; Mycoplasma; Niacinamide; Palmitic Acids; Riboflavin; Succinates; Thiamine; Thioctic Acid | 1969 |
Studies on intestinal absorption of amino acids and a dipeptide in a case of Hartnup disease.
Topics: Adult; Alanine; Amino Acids; Chromatography, Paper; Dipeptides; Female; Hartnup Disease; Histidine; Humans; Intestinal Absorption; Intestine, Small; Niacinamide; Phenylalanine; Radiography; Tryptophan | 1970 |
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism.
Topics: Alanine; Allopurinol; Amino Acids; Animals; Brain; Brain Chemistry; Carbon Isotopes; Carboxy-Lyases; Histamine; Kynurenic Acid; Kynurenine; Male; Methanol; Methyldopa; Mixed Function Oxygenases; Niacinamide; Nicotinic Acids; Nitroglycerin; ortho-Aminobenzoates; Phenylalanine; Phenylbutyrates; Picolinic Acids; Pyridines; Pyridoxal Phosphate; Pyridoxine; Rats; Serotonin; Sulfuric Acids; Time Factors; Tryptophan; Tryptophan Oxygenase; Xanthurenates | 1970 |
Model reactions which establish a facile reduction of pyridoxal phosphate and analogs by 1,4-dihydropyridines.
Topics: Alanine; Aldehydes; Cations, Divalent; Chemical Phenomena; Chemistry; Deuterium; Hydrogen; Hydrogen-Ion Concentration; Hydroquinones; Imines; Kinetics; Magnetic Resonance Spectroscopy; Methanol; Models, Chemical; Niacinamide; Oxidation-Reduction; Pyridines; Pyridoxal; Pyridoxal Phosphate; Spectrophotometry, Ultraviolet | 1973 |
Effect of combined administration of tryptophan with putative tryptophan pyrrolase inhibitors, DL-3-pyridylalanine, allopurinol or nicotinamide, on brain serotonin concentration.
Topics: Alanine; Allopurinol; Animals; Brain Chemistry; Liver; Male; Niacinamide; Rats; Rats, Inbred Strains; Serotonin; Tryptophan; Tryptophan Oxygenase | 1984 |
Active site modifications in a double mutant of liver alcohol dehydrogenase: structural studies of two enzyme-ligand complexes.
Topics: Alanine; Alcohol Dehydrogenase; Alcohol Oxidoreductases; Animals; Binding Sites; Coenzymes; Crystallography, X-Ray; Horses; Ligands; Liver; Models, Molecular; NAD; Niacinamide; Phenylalanine; Structure-Activity Relationship; Substrate Specificity; Tryptophan; Valine | 1998 |
STUDIES ON MORPHINE. IV. EFFECTS OF SOME METABOLITES ON THE "ABSTINENCE SYNDROME" TO MORPHINE ON WHITE MICE.
Topics: Alanine; Cyanides; Fluoroacetates; Glutamine; Iodoacetates; Mice; Morphine; NAD; Nalorphine; Niacin; Niacinamide; Pharmacology; Pyridines; Pyridoxine; Research; Serine; Toxicology; Tryptophan | 1963 |
A pilot study to investigate effects of inulin on Caco-2 cells through in vitro metabolic fingerprinting.
Topics: Alanine; Analysis of Variance; Caco-2 Cells; Colon; Fermentation; Glucose; Glutamic Acid; Humans; Inulin; Ketoglutaric Acids; Lactic Acid; Magnetic Resonance Spectroscopy; Niacin; Niacinamide; Proline; Succinic Acid | 2003 |
Relaxing the nicotinamide cofactor specificity of phosphite dehydrogenase by rational design.
Topics: Alanine; Amino Acid Sequence; Chromatography, High Pressure Liquid; Computer Simulation; Enzyme Stability; Escherichia coli Proteins; Glutamic Acid; Hot Temperature; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; NADH, NADPH Oxidoreductases; NADP; Niacinamide; Protein Engineering; Sequence Homology, Amino Acid; Substrate Specificity; Thermodynamics | 2003 |
Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+.
Topics: Alanine; Animals; Asparagine; Carbon-Carbon Ligases; Cloning, Molecular; Crystallography, X-Ray; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); NAD; Niacinamide; Oxidoreductases; Plasmodium falciparum; Protein Binding; Structure-Activity Relationship; Substrate Specificity; Surface Plasmon Resonance; Triclosan | 2004 |
Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition.
Topics: Alanine; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Blotting, Western; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Mice; Mice, Knockout; Mice, Transgenic; Neuroendocrine Tumors; Niacinamide; Pancreatic Neoplasms; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Receptors, Fibroblast Growth Factor; Sorafenib; Treatment Outcome; Triazines; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.
Topics: Alanine; Azepines; Binding Sites; Cathepsin K; Cathepsin L; Cathepsins; Computer Simulation; Humans; Niacinamide; Protease Inhibitors; Stereoisomerism; Structure-Activity Relationship | 2011 |
Identification and validation of urinary metabolite biomarkers for major depressive disorder.
Topics: Adult; Alanine; Biomarkers; Depressive Disorder, Major; Female; Formates; Homovanillic Acid; Humans; Male; Malonates; Metabolome; Metabolomics; Niacinamide; Nuclear Magnetic Resonance, Biomolecular; Phenylacetates | 2013 |
In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma.
Topics: Alanine; alpha-Fetoproteins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Hepatocellular; Cetuximab; Dasatinib; Doxorubicin; Drug Screening Assays, Antitumor; Epothilones; Gefitinib; Humans; Indoles; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperidines; Pyridones; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thiazoles; Triazines | 2013 |
A novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity.
Topics: Alanine; Alkynes; Aminoglycosides; Animals; Anti-Bacterial Agents; Apoptosis; Blotting, Western; Cell Count; Chick Embryo; Cytosol; Ear Diseases; Enzyme Activation; Evoked Potentials, Auditory, Brain Stem; Glycine; Hair Cells, Auditory; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred CBA; Niacinamide; Organ Culture Techniques; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; RNA, Ribosomal; Sorafenib | 2013 |
Brivanib and FOLFOX in hepatocellular carcinoma: finding the common themes among negative trials.
Topics: Alanine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Niacinamide; Palliative Care; Phenylurea Compounds; Protein Kinase Inhibitors; Salvage Therapy; Sorafenib; Triazines | 2013 |
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.
Topics: Alanine; Animals; Ascites; Cytokines; DNA Primers; Fatty Liver; Fibroblast Growth Factors; Microcirculation; Niacinamide; Non-alcoholic Fatty Liver Disease; Phenylurea Compounds; Platelet-Derived Growth Factor; Positron-Emission Tomography; Rats; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Splanchnic Circulation; Triazines; Vascular Endothelial Growth Factor A | 2014 |
Brivanib for hepatocellular carcinoma trials: selection bias from barcelona clinic liver cancer stage?
Topics: Alanine; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Salvage Therapy; Triazines | 2014 |
Reply to X. Qi et al.
Topics: Alanine; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Salvage Therapy; Triazines | 2014 |
Adipocyte dysfunction in rats with streptozotocin-nicotinamide-induced diabetes.
Topics: Adipocytes; Adipose Tissue; Alanine; Animals; Diabetes Mellitus, Experimental; Glucose; Lipogenesis; Lipolysis; Niacinamide; Rats; Streptozocin | 2014 |
Systemic therapy in HCC: lessons from brivanib.
Topics: Alanine; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Salvage Therapy; Triazines | 2014 |
Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.
Topics: Aged; Alanine; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; France; Hand-Foot Syndrome; Humans; Intra-Abdominal Fat; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Retrospective Studies; Sarcopenia; Sorafenib; Survival Rate; Tomography, X-Ray Computed; Triazines | 2015 |
Influence of low O
Topics: Alanine; Atmosphere; Carbon Dioxide; Cluster Analysis; Color; Food Packaging; Food Storage; Glycine max; Inositol; Metabolomics; Micronutrients; Multivariate Analysis; Niacinamide; Oxygen; Seeds; Time Factors; Vegetables | 2020 |
Characterization of nitrilases from Variovorax boronicumulans that functions in insecticide flonicamid degradation and β-cyano-L-alanine detoxification.
Topics: Alanine; Aminohydrolases; Comamonadaceae; Escherichia coli; Insecticides; Niacinamide | 2022 |
Studying the Parkinson's disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot study.
Topics: Aged; Alanine; Betaine; Cheminformatics; Exposome; Humans; Metabolome; Metabolomics; Neurodegenerative Diseases; Niacinamide; Parkinson Disease; Pilot Projects | 2022 |
NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy.
Topics: Alanine; Animals; Aspartic Acid; Biomarkers; Cardiomyopathy, Dilated; Coxsackievirus Infections; Enterovirus B, Human; Glutamic Acid; Glutamine; Glycine; Mice; Mice, Inbred BALB C; Myocarditis; Niacin; Niacinamide; Serine; Taurine; Threonine | 2022 |